Načítá se...
Are There Patients with T1-T2, Node-Negative Breast Cancer Who Are “High-Risk” for Locoregional Recurrence?
BACKGROUND: Indications for postmastectomy radiotherapy (PMRT) in T1-T2, node negative (N0) breast cancer with “high-risk” features are controversial. The EORTC 22922 and MA20 trials reporting improved 10-year disease-free survival with nodal irradiation included high-risk N0 patients, but benefits...
Uloženo v:
| Vydáno v: | Cancer |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5498246/ https://ncbi.nlm.nih.gov/pubmed/28334423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30658 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|